This paper is in the following e-collection/theme issue:

Clinical Information and Decision Making (1573) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (175) Drug Repurposing and Off-Label Use (27) Digital Health Reporting Standards, Quality and Transparency in e-Research (92)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65872, first published .
Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Detection of Clinically Significant Drug-Drug Interactions in Fatal Torsades de Pointes: Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System

Authors of this article:

Huanhuan Ji1 Author Orcid Image ;   Meiling Gong1, 2 Author Orcid Image ;   Li Gong3 Author Orcid Image ;   Ni Zhang4 Author Orcid Image ;   Ruiou Zhou1 Author Orcid Image ;   Dongmei Deng1 Author Orcid Image ;   Ya Yang1 Author Orcid Image ;   Lin Song1 Author Orcid Image ;   Yuntao Jia1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.